Atorvastatinfigure1 (Atorvastatinfigure1)
Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7528
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)
This text provides information on the cumulative incidence (%) of an event in a study comparing Atorvastatin to a Placebo over a period of 3.5 years. The hazard ratio (HR) is reported as 0.64 with a confidence interval of 0.50-0.83 and a p-value of 0.0005.*
Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)
This description provides data on the cumulative hazard (%) for a placebo group and a group treated with Atorvastatin, indicating a Hazard Ratio (HR) of 0.63 (with a 95% confidence interval of 0.48-0.83, p-value=0.001). The chart also shows the time to the first primary endpoint over a four-year follow-up period.*
Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)
This data shows the percentage of subjects experiencing events after taking Atorvastatin 10 mg and Atorvastatin 80 mg, with a hazard ratio (HR) of 0.78 (0.69-0.89) and a p-value of 0.0002. It also provides information on the time to the first major cardiovascular endpoint in years.*
Label Image (Lbl500907528)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
